
    
      This study consisted of 3 visits. Visit 1 (Day1, Screening), minimum (min) of 7 days and
      maximum (max) of 28 days gap followed by Visit 2 (Day 2, pain-state assessment), a recovery
      period of min of 2 days and max of 30 days followed by Visit 3 (Day 3, pain-free assessment).
      Participants received treatment once only on Visit 2.
    
  